176 related articles for article (PubMed ID: 37257140)
1. Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms.
Riechelmann RP; Taboada RG; de Jesus VHF; Iglesia M; Trikalinos NA
Am Soc Clin Oncol Educ Book; 2023 May; 43():e389278. PubMed ID: 37257140
[TBL] [Abstract][Full Text] [Related]
2. The evolving landscape of neuroendocrine tumors.
Bergsland EK
Semin Oncol; 2013 Feb; 40(1):4-22. PubMed ID: 23391109
[TBL] [Abstract][Full Text] [Related]
3. Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review.
Pusceddu S; De Braud F; Festinese F; Bregant C; Lorenzoni A; Maccauro M; Milione M; Concas L; Formisano B; Leuzzi L; Mazzaferro V; Buzzoni R
Future Oncol; 2015; 11(13):1947-59. PubMed ID: 26161929
[TBL] [Abstract][Full Text] [Related]
4. Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues.
Agarwal P; Mohamed A
Curr Treat Options Oncol; 2022 Sep; 23(9):1233-1246. PubMed ID: 35939200
[TBL] [Abstract][Full Text] [Related]
5. Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope.
Giri S; Sahoo J
World J Gastroenterol; 2024 Mar; 30(12):1670-1675. PubMed ID: 38617746
[TBL] [Abstract][Full Text] [Related]
6. Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review.
Regalla DKR; Deep O; Paluri RK
Chin Clin Oncol; 2023 Dec; 12(6):67. PubMed ID: 38073310
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives.
Modica R; Liccardi A; Minotta R; Cannavale G; Benevento E; Colao A
Expert Rev Endocrinol Metab; 2022 Sep; 17(5):389-403. PubMed ID: 35822906
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapy: New Radiolabeled Somatostatin Analogs to Treat Gastroenteropancreatic Neuroendocrine Tumors.
Boucher JE; Sommers R
Clin J Oncol Nurs; 2018 Oct; 22(5):565-568. PubMed ID: 30239510
[TBL] [Abstract][Full Text] [Related]
9. Genomic Profiles and Current Therapeutic Agents in Neuroendocrine Neoplasms.
Ohmoto A; Morizane C
Curr Drug Targets; 2020; 21(4):389-405. PubMed ID: 31633473
[TBL] [Abstract][Full Text] [Related]
10. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M; Cárdenas-Salas J; Álvarez-Escolá C
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121432
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.
Raj N; Reidy-Lagunes D
Hematol Oncol Clin North Am; 2016 Feb; 30(1):119-33. PubMed ID: 26614372
[TBL] [Abstract][Full Text] [Related]
13. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.
Pasricha G; Padhi P; Daboul N; Monga DK
Clin Ther; 2017 Nov; 39(11):2146-2157. PubMed ID: 29173655
[TBL] [Abstract][Full Text] [Related]
14. Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors.
Cho CM
Korean J Gastroenterol; 2019 Mar; 73(3):124-131. PubMed ID: 31013555
[TBL] [Abstract][Full Text] [Related]
15. Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials.
Cives M; Soares HP; Strosberg J
Curr Opin Oncol; 2016 Jul; 28(4):359-66. PubMed ID: 27138571
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.
Xu G; Wang Y; Zhang H; She X; Yang J
Future Oncol; 2021 Mar; 17(9):1069-1081. PubMed ID: 33136448
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy for advanced pancreatic neuroendocrine tumors: an update.
Reidy-Lagunes DL
J Natl Compr Canc Netw; 2012 Jun; 10(6):777-83. PubMed ID: 22679119
[TBL] [Abstract][Full Text] [Related]
18. Current treatment status in pancreatic neuroendocrine neoplasms.
Liu DJ; Hua R; Sun YW
Chin Clin Oncol; 2019 Apr; 8(2):20. PubMed ID: 31070040
[TBL] [Abstract][Full Text] [Related]
19. Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms.
Boutzios G; Kaltsas G
Front Horm Res; 2015; 44():40-57. PubMed ID: 26303703
[TBL] [Abstract][Full Text] [Related]
20. Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.
Hauser H; Gerson DS; Reidy-Lagunes D; Raj N
Curr Treat Options Oncol; 2019 Nov; 20(12):87. PubMed ID: 31776785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
